[Asia Economy Reporter Eunmo Koo] FutureChem announced on the 16th that it has decided on a facility investment worth 8 billion KRW to build a new product manufacturing plant and secure new drug R&D facilities. The investment amount represents 18.9% of its equity capital, and the investment period is until December 31, 2022.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing